Evaluation of ocular surface glycocalyx using lectin-conjugated fluorescein.
OBJECTIVE
A glycocalyx plays important roles in the ocular surface epithelium, but there is no direct simple method to evaluate ocular surface glycocalyx. We tested a wheat germ agglutinin conjugate of fluorescein (F-WGA) as a marker to demonstrate ocular surface glycocalyx in vivo.


METHODS
After a 5% F-WGA solution was applied to the eyes of eight healthy volunteers, fluorescent intensities of the central cornea and bulbar conjunctiva were measured by fluorophotometry. A 10% fluorescein-conjugated dextran solution served as the control. Changes in fluorescent intensities of the ocular surface following a challenge with 5% N-acetyl cysteine, a conventional mucolytic agent, were tested in the second experiment. Saline instillation served as a control.


RESULTS
The ocular surface was diffusely stained by F-WGA. Breakup of the precorneal tear film was not apparent, possibly because F-WGA was bound to the glycocalyx of the ocular surface epithelium. F-WGA fluorescent intensities were high in the superior, nasal, and inferior regions of the bulbar conjunctiva and low in the temporal conjunctiva and cornea. No such regional differences were observed with fluorescein-conjugated dextran. F-WGA fluorescent intensities decreased significantly with N-acetyl cysteine instillation, whereas they were not affected by saline instillation.


CONCLUSIONS
The fluorophotometric method may be used to evaluate the glycocalyx quantitatively in the ocular surface in vivo.
Mochizuki
Hiroshi
H
Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan.
Fukui
Masaki
M
Hatou
Shin
S
Yamada
Masakazu
M
Tsubota
Kazuo
K
Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2602-9
9856770
Arch Ophthalmol. 1983 Dec;101(12):1869-72
6651590
Acta Ophthalmol (Copenh). 1968;:Suppl 95:1+
4170134
Graefes Arch Clin Exp Ophthalmol. 1990;228(6):528-32
2265767
Cornea. 2006 Feb;25(2):176-81
16371777
J Autoimmun. 1989 Aug;2(4):495-500
2675893
Arch Ophthalmol. 1992 Jul;110(7):984-93
1637285
Acta Ophthalmol (Copenh). 1986 Aug;64(4):445-50
3022541
Exp Eye Res. 1988 Apr;46(4):485-97
3289955
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2487-95
12766047
Ophthalmology. 1992 Apr;99(4):605-17
1374875
Int Rev Cytol. 2003;231:1-49
14713002
Acta Ophthalmol (Copenh). 1991 Jun;69(3):371-6
1927322
Exp Eye Res. 1984 May;38(5):439-47
6745321
Invest Ophthalmol Vis Sci. 2000 May;41(6):1316-26
10798646
Br J Ophthalmol. 2004 Mar;88(3):377-83
14977773
Am J Ophthalmol. 2003 Sep;136(3):513-9
12967806
Invest Ophthalmol Vis Sci. 1995 Aug;36(9):1818-27
7635656
Br J Ophthalmol. 2005 Dec;89(12):1655-9
16299150
J Mol Biol. 1984 Sep 5;178(1):91-104
6548265
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1046-58
7510270
Dev Ophthalmol. 2008;41:1-20
18453758
Cornea. 1985-1986;4(1):30-4
2419028
Curr Eye Res. 1999 Jul;19(1):4-11
10415451